Scarica l'app Stockscreener
2.04
1.49%
0.03
Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
29.77%
16.11
|
12.41 | 15.16 | 13.89 | 15.13 |
| Cost Of Revenue |
18.39%
5.697
|
4.812 | 5.541 | 4.702 | 4.881 |
| Gross Profit |
36.98%
10.41
|
7.599 | 9.624 | 9.186 | 10.25 |
| Operating Expenses |
4.09%
11.19
|
11.66 | 11.59 | 10.69 | 17.88 |
| Operating Income/Loss |
80.88%
-0.777
|
-4.064 | -1.97 | -1.504 | -7.623 |
| Income/Loss From Continuing Operations Before Tax |
99.93%
-0.004
|
-5.608 | -10.58 | 1.965 | -19.44 |
| Income Tax Expense/Benefit |
10.00%
0.011
|
0.01 | - | - | 0.437 |
| Income/Loss From Continuing Operations After Tax |
99.73%
-0.015
|
-5.618 | -10.58 | 1.965 | -19.88 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | - | 0.062 |
| Net Income/Loss |
99.73%
-0.015
|
-5.618 | -10.58 | 1.965 | -19.82 |
1.55%
5.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):